Dengue Virus Infections among Peace Corps Volunteers in Timor-Leste, 2018-2019.


Journal

The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507

Informations de publication

Date de publication:
26 04 2021
Historique:
received: 07 01 2021
accepted: 08 03 2021
pubmed: 27 4 2021
medline: 27 1 2022
entrez: 26 4 2021
Statut: epublish

Résumé

Dengue is an ongoing health risk for Peace Corps Volunteers (PCVs) working in the tropics. On May 2019, the Peace Corps Office of Health Services notified the Centers for Disease Control and Prevention (CDC) of a dengue outbreak among PCVs in Timor-Leste. The purpose of this investigation was to identify the clinical, demographic, and epidemiological characteristics of PCVs with dengue and recommend dengue preventive measures. To identify PCVs with dengue and describe disease severity, the medical records of PCVs reporting fever during September 2018-June 2019 were reviewed. To identify factors associated with dengue virus (DENV) infection, we administered a questionnaire on demographics, travel history, and mosquito avoidance behaviors and collected blood specimens to detect the anti-DENV IgM antibody to diagnose recent infection. Of 35 PCVs in-country, 11 (31%) tested positive for dengue (NS1, IgM, PCR), eight requiring hospitalization and medical evacuation. Among 27 (77%) PCVs who participated in the investigation, all reported having been recently bitten by mosquitoes and 56% reported being bitten most often at home; only 16 (59%) reported having screens on bedroom windows. Nearly all (93%) PCVs reported using a bed net every night; fewer (70%) reported using mosquito repellent at least once a day. No behaviors were significantly associated with DENV infection. Raising awareness of dengue risk among PCVs and continuing to encourage mosquito avoidance behavior to prevent dengue is critical. Access to and use of measures to avoid mosquito bites should be improved or implemented. Peace Corps medical officers should continue to receive an annual refresher training on dengue clinical management.

Identifiants

pubmed: 33901000
doi: 10.4269/ajtmh.21-0020
pii: tpmd210020
pmc: PMC8176509
doi:
pii:

Substances chimiques

Immunoglobulin M 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2202-2209

Auteurs

Liliana Sánchez-González (L)

1Dengue Branch, Centers for Disease Control and Prevention, San Juan, Puerto Rico.

Margaret Venuto (M)

2Epidemiology and Surveillance Unit, Office of Health Services, United States Peace Corps, Washington, District of Columbia.

Scott Poe (S)

2Epidemiology and Surveillance Unit, Office of Health Services, United States Peace Corps, Washington, District of Columbia.

Chelsea G Major (CG)

1Dengue Branch, Centers for Disease Control and Prevention, San Juan, Puerto Rico.

Leonardus Baskara (L)

3Timor-Leste Country Office, Office of Health Services, U.S. Peace Corps, Washington, District of Columbia.

Sevinj Abdiyeva (S)

3Timor-Leste Country Office, Office of Health Services, U.S. Peace Corps, Washington, District of Columbia.

Daniel Murphy (D)

2Epidemiology and Surveillance Unit, Office of Health Services, United States Peace Corps, Washington, District of Columbia.

Jorge L Munoz-Jordan (JL)

1Dengue Branch, Centers for Disease Control and Prevention, San Juan, Puerto Rico.

Freddy A Medina (FA)

1Dengue Branch, Centers for Disease Control and Prevention, San Juan, Puerto Rico.

Gabriela Paz-Bailey (G)

1Dengue Branch, Centers for Disease Control and Prevention, San Juan, Puerto Rico.

Kyle Petersen (K)

2Epidemiology and Surveillance Unit, Office of Health Services, United States Peace Corps, Washington, District of Columbia.

Karen Becker (K)

2Epidemiology and Surveillance Unit, Office of Health Services, United States Peace Corps, Washington, District of Columbia.

Tyler M Sharp (TM)

1Dengue Branch, Centers for Disease Control and Prevention, San Juan, Puerto Rico.
4U.S. Public Health Service, Rockville, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH